Effectiveness of Anti-CD7 Treatment in Different Mice Models
Author Information
Author(s): Flavell D J, Warnes S L, Noss A L, Flavell S U
Primary Institution: The Simon Flavell Leukaemia Research Unit, Division of Cancer Sciences, University of Southampton School of Medicine
Hypothesis
The effectiveness of anti-CD7 antibody and immunotoxin treatment varies between different mouse models of T-cell leukaemia.
Conclusion
The anti-CD7 treatment was significantly less effective in NOD/SCID mice compared to SCID mice.
Supporting Evidence
- HB2-SAPORIN treatment significantly prolonged disease-free survival in SCID mice.
- HB2-F(ab)2-SAPORIN was less effective in SCID mice, with 80% developing leukaemia.
- NOD/SCID mice showed no therapeutic effect from HB2 antibody treatment.
Takeaway
This study found that a treatment for leukaemia worked well in one type of mouse but not in another type, which helps scientists understand how to test new medicines better.
Methodology
Mice were injected with human T-ALL cells and treated with anti-CD7 antibody or immunotoxins, followed by monitoring for disease development.
Potential Biases
Potential bias due to the limited number of mouse models used in the study.
Limitations
The study was limited to two specific mouse models and may not represent all types of leukaemia or responses in humans.
Participant Demographics
Mice used were SCID and NOD/SCID strains.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website